RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19079180http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19079180http://www.w3.org/2000/01/rdf-schema#comment"In a nasal vaccine against influenza, the activation of natural killer T (NKT) cells by intranasal coadministration of alpha-galactosylceramide (alpha-GalCer) can potently enhance protective immune responses. The results of this study show that the NKT cell-activated nasal vaccine can induce an effective cross-protection against different strains of influenza virus, including H5 type. To analyze the mechanism of NKT cell activation by this nasal vaccine, we prepared fluorescence-labeled alpha-GalCer by which we detect a direct interaction between NKT cells and alpha-GalCer-stored dendritic cells in nasal mucosa-associated tissues. Accordingly, although very few NKT cells exist at mucosa, the nasal vaccination induced a localized increase in NKT cell population, which is partly dependent on CXCL16/CXCR6. Furthermore, we found that NKT cell activation stimulates mucosal IgA production by a mechanism that is dependent on interleukin (IL)-4 production. These results strengthen the basis of nasal vaccination via NKT cell activation, which can induce immune cross-protection."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.org/dc/terms/identifier"doi:10.1038/mi.2008.2"xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Jiang X."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Mori K."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Ohno H."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Nagata Y."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Odagiri T."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Taniguchi M."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Tashiro M."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Yonehara S."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Sata T."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Hase K."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Hasegawa H."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Tashiro T."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Ichinohe T."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Shimaoka T."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Seino K.I."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/author"Kamijuku H."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/name"Mucosal Immunol"xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/pages"208-218"xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/title"Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses."xsd:string
http://purl.uniprot.org/citations/19079180http://purl.uniprot.org/core/volume"1"xsd:string
http://purl.uniprot.org/citations/19079180http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19079180